Related Experiment Videos
Relative role of catecholamines in head-shaking of infant rats
Insights
This study reveals that both dopaminergic and noradrenergic mechanisms contribute to head-shaking (H-S) in infant rats. These findings differentiate H-S from other stereotyped behaviors and highlight specific receptor involvement.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- Head-shaking (H-S) is a complex motor behavior observed in infant rats.
- The precise neurochemical underpinnings of H-S, particularly during early development, remain incompletely understood.
Purpose of the Study:
- To investigate the role of catecholaminergic systems in mediating H-S in infant rats.
- To differentiate the neurochemical pathways of H-S from those involved in other stereotyped behaviors.
Main Methods:
- Administered apomorphine and amphetamine to infant rats aged 4-14 days to assess H-S induction.
- Utilized neuroleptic drugs (chlorpromazine, haloperidol) and adrenergic antagonists (phenoxybenzamine, propranolol) to block amphetamine-induced H-S.
Main Results:
- Apomorphine induced H-S in 4-day-old rats, while amphetamine did not; however, amphetamine potentiated apomorphine-induced H-S.
- D-amphetamine-induced H-S was blocked by phenoxybenzamine, indicating noradrenergic involvement.
- Other stereotyped motor patterns remained unaffected when H-S was blocked.
Conclusions:
- Both dopaminergic and noradrenergic mechanisms are implicated in infant rat H-S.
- The neurochemical basis of H-S appears distinct from other stereotyped motor patterns.
- Adrenergic receptor antagonism selectively impacts H-S, supporting its unique neurobiological profile.
Abstract:
The relative contribution of catecholaminergic mechanisms in head-shaking (H-S) of infant rats was explored by comparing the H-S inducing effects of apomorphine and amphetamine in rats from 4-14 days old, and the blocking effect of neuroleptic drugs (chlorpromazine and haloperidol) and more specific alpha- and beta-adrenergic receptor antagonists (phenoxybenzamine and propranolol), on amphetamine induced head-shaking. As apomorphine, but not amphetamine, may induce H-S in four-day-old rats, and the latter drug potentiates apomorphine induced H-S, even in days in which, if injected alone it has no effect, it is suggested that both dopaminergic and noradrenergic mechanisms are involved in H-S, thus differentiating this motor item from other motor patterns included in stereotyped behaviour. This suggestion is further supported by the demonstration that while D-amphetamine induced H-S is blocked by phenoxybenzamine, other stereotyped motor patterns continue unimpaired.